TIRILAZAD
Spinal Cord Injury
National Institute of Neurological Disorders and Stroke (NINDS)Small moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 81/ 100
Competitive context
19 Active assets in the Spinal Cord Injury cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Pregabalin Ju Seok Ryu | Phase 4 | BBB |
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)- MetroHealth Medical Center | Phase 4 | BB |
Semaglutide James J. Peters Veterans Affairs Medical Center | Phase 4 | BB |
VENLOR University of Washington | Phase 4 | BB |
Brivaracetam University of Minnesota | Phase 3 | BB |
View all 42 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →